Senti Biosciences
SNTI • NASDAQ
Senti Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Timothy K. Lu, with a market cap of $24.6M.
CEOTimothy K. Lu
Next Earnings
Upcoming earnings announcement for Senti Biosciences
Date
Tuesday, May 5, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.49
Earnings History
Past 12 earnings reports for Senti Biosciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Q4 2025 | -$0.53Est: -$0.46 | -15.2% | $22.0KEst: $500.0K | -95.6% |  10-K |
| Nov 13, 2025 | Q3 2025 | -$0.69Est: -$0.58 | -19.0% | -Est: $166.7K | -100.0% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.56Est: -$0.90 | +37.8% | -Est: $250.0K | -100.0% | 10-Q |
| May 6, 2025 | Q1 2025 | -$1.41 | — | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.67Est: -$3.13 | +78.6% | -Est: $2.8M | -100.0% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$6.31 | — | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$2.45 | — | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$2.60 | — | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$4.20Est: -$2.30 | -82.6% | -Est: $300.0K | -100.0% | 10-K/A |
| Nov 13, 2023 | Q3 2023 | -$2.50Est: -$4.40 | +43.2% | $338.0KEst: $700.0K | -51.7% | — |
| Aug 11, 2023 | Q2 2023 | -$4.20Est: -$4.80 | +12.5% | $937.0KEst: $500.0K | +87.4% | — |
| May 9, 2023 | Q1 2023 | -$4.20Est: -$4.30 | +2.3% | $1.3MEst: $470.0K | +173.6% | — |